当前位置:首页 > 股票大全 > 天康生物 002100 财务分析

天康生物财务分析

整理编辑:168股票行情网www.gphq168.com    数据来源:互联网 经供参考

天康生物(002100)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入3,776,851,559.4119,025,806,286.5914,705,995,884.828,963,149,801.46
营业总成本3,678,286,988.7519,995,177,780.1415,185,082,263.259,367,051,782.51
营业利润90,552,171.4-1,446,037,620.65-533,516,873.58-482,145,468.3
利润总额77,900,367.67-1,492,968,178.4-567,189,830.55-498,522,738.72
净利润60,176,209.17-1,516,427,334.32-588,801,239.44-520,364,408.37
其他综合收益-52,610,170.5849,694,692.882,814,083.8322,490,620.31
综合收益总额7,566,038.59-1,466,732,641.44-585,987,155.61-497,873,788.06
天康生物(002100)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计9,357,175,806.528,960,844,383.948,962,014,010.210,980,343,198.32
非流动资产合计7,809,433,517.597,790,815,230.477,654,771,821.587,531,835,886.56
资产总计17,166,609,324.1116,751,659,614.4116,616,785,831.7818,512,179,084.88
流动负债合计7,095,293,961.897,087,194,350.585,466,965,264.176,572,496,615.66
非流动负债合计2,131,733,886.831,749,708,337.752,352,732,986.973,023,358,556.92
负债合计9,227,027,848.728,836,902,688.337,819,698,251.149,595,855,172.58
归属于母公司股东权益合计6,411,812,716.196,410,600,615.27,154,200,919.317,227,356,096.93
股东权益合计7,939,581,475.397,914,756,926.088,797,087,580.648,916,323,912.3
负债和股东权益合计17,166,609,324.1116,751,659,614.4116,616,785,831.7818,512,179,084.88
天康生物(002100)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计3,542,952,311.9520,096,758,837.7314,236,368,190.538,930,707,952.46
经营活动现金流出小计3,876,802,981.3318,344,947,571.9510,937,356,234.447,372,042,143.43
经营活动产生的现金流量净额-333,850,669.381,751,811,265.783,299,011,956.091,558,665,809.03
投资活动现金流入小计13,796,062.92898,688,823.94677,467,142.48665,432,413.75
投资活动现金流出小计201,275,053.211,673,683,965.61,105,142,364.52961,379,304.58
投资活动产生的现金流量净额-187,478,990.29-774,995,141.66-427,675,222.04-295,946,890.83
筹资活动现金流入小计1,251,700,0004,968,343,604.412,147,371,027.061,581,757,302.77
筹资活动现金流出小计854,680,708.586,473,530,594.314,471,220,270.222,331,874,775.21
筹资活动产生的现金流量净额397,019,291.42-1,505,186,989.9-2,323,849,243.16-750,117,472.44
汇率变动对现金及现金等价物的影响----
现金及现金等价物净增加额-124,310,368.25-528,370,865.78547,487,490.89512,601,445.76
期末现金及现金等价物余额2,548,274,731.172,672,585,099.423,748,443,456.093,713,557,410.96
天康生物002100相关数据
今日股市大盘指数